97 related articles for article (PubMed ID: 34544532)
1. Luteolin-Loading Her-2 Nanospheres Enhances Targeting and Therapeutic Effects of Breast Cancer.
Xiao C; Wang X; Shen J; Xia Y; Qiu S; Liang X; Gu W
J Biomed Nanotechnol; 2021 Aug; 17(8):1545-1553. PubMed ID: 34544532
[TBL] [Abstract][Full Text] [Related]
2. Luteolin-loading of Her-2-poly (lactic-co-glycolic acid) nanoparticles and proliferative inhibition of gastric cancer cells via targeted regulation of forkhead box protein O1.
Ding J; Li Q; He S; Xie J; Liang X; Wu T; Li D
J Cancer Res Ther; 2020; 16(2):263-268. PubMed ID: 32474511
[TBL] [Abstract][Full Text] [Related]
3. [Luteolin reverses OPCML methylation to inhibit proliferation of breast cancer MDA-MB-231 cells].
Dong X; Zheng T; Zhang Z; Bai X; Li H; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):550-555. PubMed ID: 32895125
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin-decorated vs PEGylated zein nanospheres for combined aromatase inhibitor and herbal therapy of breast cancer.
El-Lakany SA; Elgindy NA; Helmy MW; Abu-Serie MM; Elzoghby AO
Expert Opin Drug Deliv; 2018 Sep; 15(9):835-850. PubMed ID: 30067113
[TBL] [Abstract][Full Text] [Related]
5. [Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway].
Lin YJ; Huang YH; Zhen YZ; Liu XJ; Zhen YS
Yao Xue Xue Bao; 2008 Nov; 43(11):1099-105. PubMed ID: 19239027
[TBL] [Abstract][Full Text] [Related]
6. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.
Lee EJ; Oh SY; Sung MK
Food Chem Toxicol; 2012 Nov; 50(11):4136-43. PubMed ID: 22926442
[TBL] [Abstract][Full Text] [Related]
7. MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway.
Wu HT; Liu YE; Hsu KW; Wang YF; Chan YC; Chen Y; Chen DR
Am J Chin Med; 2020; 48(5):1221-1241. PubMed ID: 32668964
[TBL] [Abstract][Full Text] [Related]
8. Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo.
Feng J; Zheng T; Hou Z; Lv C; Xue A; Han T; Han B; Sun X; Wei Y
Oncol Rep; 2020 Nov; 44(5):2231-2240. PubMed ID: 33000272
[TBL] [Abstract][Full Text] [Related]
9. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3.
Yang MY; Wang CJ; Chen NF; Ho WH; Lu FJ; Tseng TH
Chem Biol Interact; 2014 Apr; 213():60-8. PubMed ID: 24525192
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of luteolin on the angiogenesis of chick chorioallantoic membrane and invasion of breast cancer cells via downregulation of AEG-1 and MMP-2].
Jiang Y; Xie KP; Huo HN; Wang LM; Zou W; Xie MJ
Sheng Li Xue Bao; 2013 Oct; 65(5):513-8. PubMed ID: 24129732
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
[TBL] [Abstract][Full Text] [Related]
14. Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway.
Zhang L; Liu Q; Huang L; Yang F; Liu A; Zhang J
Biochem Biophys Res Commun; 2020 Oct; 531(3):364-371. PubMed ID: 32800546
[TBL] [Abstract][Full Text] [Related]
15. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
Yao X; Jiang W; Yu D; Yan Z
Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK-BR-3 breast cancer cell proliferation.
Brockhoff G; Heckel B; Schmidt-Bruecken E; Plander M; Hofstaedter F; Vollmann A; Diermeier S
Cell Prolif; 2007 Aug; 40(4):488-507. PubMed ID: 17635517
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors.
Shih YL; Liu HC; Chen CS; Hsu CH; Pan MH; Chang HW; Chang CH; Chen FC; Ho CT; Yang YY; Ho YS
J Agric Food Chem; 2010 Jan; 58(1):235-41. PubMed ID: 19921817
[TBL] [Abstract][Full Text] [Related]
19. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells.
Im E; Yeo C; Lee EO
Life Sci; 2018 Sep; 209():259-266. PubMed ID: 30107166
[TBL] [Abstract][Full Text] [Related]
20. Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression.
Tu SH; Ho CT; Liu MF; Huang CS; Chang HW; Chang CH; Wu CH; Ho YS
Food Chem; 2013 Nov; 141(2):1553-61. PubMed ID: 23790951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]